Schroder Investment Management Group
MXCT icon

Schroder Investment Management Group’s MaxCyte MXCT Stock Holding History

Schroder Investment Management Group’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-136,947
Closed -$299K – 1236
2025
Q2 		$299K Buy
+136,947
New +$332K ﹤0.01% 1093
2022
Q1 		– Sell
-141,027
Closed -$1.06M – 1506
2021
Q4 		$1.06M Buy
+141,027
New +$1.51M ﹤0.01% 1024

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schroder Investment Management Group's MXCT Position: Q3 2025 in Review

Schroder Investment Management Group sold out of MaxCyte (MXCT) in Q3 2025, closing a stake of 136,947 shares — an estimated $299K sold.

Schroder Investment Management Group first reported a position in MXCT in Q4 2021 and held it in 2 quarters. The position peaked at $1.06M in Q4 2021. 112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

  • Schroder Investment Management Group reported no remaining MaxCyte position as of Q3 2025 after selling out during the quarter.
  • Schroder Investment Management Group sold 136,947 MaxCyte shares in Q3 2025, an estimated $299K.
  • Schroder Investment Management Group first reported a position in MaxCyte in Q4 2021 and held it in 2 quarters.
  • Schroder Investment Management Group's MaxCyte position peaked at $1.06M in Q4 2021.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on Schroder Investment Management Group's 13F filing for Q3 2025, filed 13 Nov 2025.